N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine

C131H94N26S2 — CID 164955789

IUPACN-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine
SMILESCc1nc2ccc(Nc3nc(-c4ccccc4)cc4ncccc34)cc2s1.Cn1cnc2ccc(Nc3nc(-c4ccccc4)cc4ncccc34)cc21.c1ccc(-c2cc3ncccc3c(Nc3ccc4cc[nH]c4c3)n2)cc1.c1ccc(-c2cc3ncccc3c(Nc3ccc4ncncc4c3)n2)cc1.c1ccc(-c2cc3ncccc3c(Nc3ccc4ncsc4c3)n2)cc1.c1ccc(-c2cc3ncccc3c(Nc3cccc4cc[nH]c34)n2)cc1
InChIInChI=1S/C22H17N5.C22H15N5.C22H16N4S.2C22H16N4.C21H14N4S/c1-27-14-24-18-10-9-16(12-21(18)27)25-22-17-8-5-11-23-20(17)13-19(26-22)15-6-3-2-4-7-15;1-2-5-15(6-3-1)20-12-21-18(7-4-10-24-21)22(27-20)26-17-8-9-19-16(11-17)13-23-14-25-19;1-14-24-18-10-9-16(12-21(18)27-14)25-22-17-8-5-11-23-20(17)13-19(26-22)15-6-3-2-4-7-15;1-2-6-15(7-3-1)19-14-20-17(9-5-12-23-20)22(26-19)25-18-10-4-8-16-11-13-24-21(16)18;1-2-5-15(6-3-1)20-14-21-18(7-4-11-23-21)22(26-20)25-17-9-8-16-10-12-24-19(16)13-17;1-2-5-14(6-3-1)18-12-19-16(7-4-10-22-19)21(25-18)24-15-8-9-17-20(11-15)26-13-23-17/h2-14H,1H3,(H,25,26);1-14H,(H,26,27);2-13H,1H3,(H,25,26);2*1-14,24H,(H,25,26);1-13H,(H,24,25)
InChIKeyBDMLQDXBINGJKV-UHFFFAOYSA-N
MW2096.51 g/mol
LogP32.56
Rot. Bonds18

About N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine

N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine (PubChem CID 164955789) has the molecular formula C131H94N26S2 and a molecular weight of 2096.51 g/mol. Its IUPAC name is N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine.

Molecular Properties

Compound NameN-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine
PubChem CID164955789
Molecular FormulaC131H94N26S2
Molecular Weight2096.51 g/mol
Exact Mass2094.76
IUPAC NameN-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine
SMILESCc1nc2ccc(Nc3nc(-c4ccccc4)cc4ncccc34)cc2s1.Cn1cnc2ccc(Nc3nc(-c4ccccc4)cc4ncccc34)cc21.c1ccc(-c2cc3ncccc3c(Nc3ccc4cc[nH]c4c3)n2)cc1.c1ccc(-c2cc3ncccc3c(Nc3ccc4ncncc4c3)n2)cc1.c1ccc(-c2cc3ncccc3c(Nc3ccc4ncsc4c3)n2)cc1.c1ccc(-c2cc3ncccc3c(Nc3cccc4cc[nH]c34)n2)cc1
InChIInChI=1S/C22H17N5.C22H15N5.C22H16N4S.2C22H16N4.C21H14N4S/c1-27-14-24-18-10-9-16(12-21(18)27)25-22-17-8-5-11-23-20(17)13-19(26-22)15-6-3-2-4-7-15;1-2-5-15(6-3-1)20-12-21-18(7-4-10-24-21)22(27-20)26-17-8-9-19-16(11-17)13-23-14-25-19;1-14-24-18-10-9-16(12-21(18)27-14)25-22-17-8-5-11-23-20(17)13-19(26-22)15-6-3-2-4-7-15;1-2-6-15(7-3-1)19-14-20-17(9-5-12-23-20)22(26-19)25-18-10-4-8-16-11-13-24-21(16)18;1-2-5-15(6-3-1)20-14-21-18(7-4-11-23-21)22(26-20)25-17-9-8-16-10-12-24-19(16)13-17;1-2-5-14(6-3-1)18-12-19-16(7-4-10-22-19)21(25-18)24-15-8-9-17-20(11-15)26-13-23-17/h2-14H,1H3,(H,25,26);1-14H,(H,26,27);2-13H,1H3,(H,25,26);2*1-14,24H,(H,25,26);1-13H,(H,24,25)
InChIKeyBDMLQDXBINGJKV-UHFFFAOYSA-N
XLogP32.56
TPSA327.82 Ų
H-Bond Donors8
H-Bond Acceptors26
Rotatable Bonds18
Heavy Atoms159
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002096.51
LogP ≤ 532.56
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1026

Analyze N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Tld-1433
CID 145722627
2-N-ethyl-6-[6-[[4-[(6-fluoroimidazo[1,5-a]pyridin-3-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl]-methylamino]-1,3-benzothiazol-2-yl]-2-N-(2-phenylethyl)-4-N-(1,2,4-thiadiazol-5-yl)quinazoline-2,4-diamine
CID 142808318
(E)-N-(1,3-benzothiazol-6-yl)-3-(6-tert-butyl-3-pyridinyl)prop-2-enamide;(E)-3-(6-tert-butyl-3-pyridinyl)-N-(1H-indol-6-yl)prop-2-enamide;(E)-3-[2-(dimethylamino)-6-(trifluoromethyl)-3-pyridinyl]-N-(1H-indol-5-yl)prop-2-enamide;(E)-N-(1H-indol-5-yl)-3-[2-piperidin-1-yl-6-(trifluoromethyl)-3-pyridinyl]prop-2-enamide;(E)-N-(1H-indol-6-yl)-3-[6-(trifluoromethyl)-3-pyridinyl]prop-2-enamide;(E)-3-[2-piperidin-1-yl-6-(trifluoromethyl)-3-pyridinyl]-N-quinolin-3-ylprop-2-enamide
CID 157061992
3,7-Bis(2,6-dimethylphenyl)-2,8-dimethyl-11-(trifluoromethyl)-3,7,13-triazoniatricyclo[7.3.1.05,13]trideca-1(12),2,7,9(13),10-pentaene;3,7-bis(2,6-dimethylphenyl)-2,8,11-trimethyl-3,7,13-triazoniatricyclo[7.3.1.05,13]trideca-1(12),2,7,9(13),10-pentaene;10,18-dimethyl-3,25-diaza-10,18,27-triazoniaheptacyclo[14.10.1.03,11.04,9.012,27.017,25.019,24]heptacosa-4,6,8,10,12(27),13,15,17,19,21,23-undecaene;10,18-dithia-3,25,27-triazoniaheptacyclo[14.10.1.03,11.04,9.012,27.017,25.019,24]heptacosa-3(11),4,6,8,12(27),13,15,17(25),19,21,23-undecaene;3,19,21-triazoniapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-3,5,7,9(21),10,12,14,16,18-nonaene;2,8,11-trimethyl-3,7-bis(2,4,6-trimethylphenyl)-3,7,13-triazoniatricyclo[7.3.1.05,13]trideca-1(12),2,7,9(13),10-pentaene
CID 159537615
1-(4H-imidazol-2-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indole-2-carbonitrile;1-[(1-methylimidazol-2-yl)methyl]-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indole-2-carbonitrile;1-[(2-methyl-1,3-thiazol-4-yl)methyl]-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indole-2-carbonitrile;1-(2H-pyrrol-4-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indole-2-carbonitrile;1-(3H-pyrrol-5-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indole-2-carbonitrile
CID 160336757
(E)-N-(1,3-benzothiazol-6-yl)-3-(6-tert-butyl-3-pyridinyl)prop-2-enamide;(E)-3-(6-tert-butyl-3-pyridinyl)-N-(1H-indol-6-yl)prop-2-enamide;(E)-N-(1H-indol-5-yl)-3-[6-(trifluoromethyl)-3-pyridinyl]prop-2-enamide;(E)-N-(1H-indol-6-yl)-3-[6-(trifluoromethyl)-3-pyridinyl]prop-2-enamide;(E)-3-[2-piperidin-1-yl-6-(trifluoromethyl)-3-pyridinyl]-N-quinolin-3-ylprop-2-enamide
CID 161221729
2,5-dimethyl-N-(7-pyridin-4-yl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;2-ethyl-N-(7-pyridin-4-yl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(4-fluoro-2-methyl-1H-inden-5-yl)-7-pyridin-4-yl-1,6-naphthyridin-5-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-6,7,8,9-tetrahydro-5H-carbazol-3-amine;7-phenyl-N-[2-(trifluoromethyl)-3H-imidazo[4,5-c]pyridin-7-yl]-1,6-naphthyridin-5-amine
CID 164947162
3-(1,3-benzothiazol-6-yl)-1-[4-(1H-1,2,4-triazol-5-yl)phenyl]-7-(2,2,2-trifluoroethylamino)-4H-pyrimido[4,5-d]pyrimidin-2-one;3-(3-methylbenzimidazol-5-yl)-1-[4-(1H-1,2,4-triazol-5-yl)phenyl]-7-(2,2,2-trifluoroethylamino)-4H-pyrimido[4,5-d]pyrimidin-2-one;3-(2-methyl-1,3-benzothiazol-6-yl)-1-[4-(1H-1,2,4-triazol-5-yl)phenyl]-7-(2,2,2-trifluoroethylamino)-4H-pyrimido[4,5-d]pyrimidin-2-one;3-(2-methylindazol-5-yl)-1-[4-(1H-1,2,4-triazol-5-yl)phenyl]-7-(2,2,2-trifluoroethylamino)-4H-pyrimido[4,5-d]pyrimidin-2-one
CID 165064808
iron(2+);bis(2-thiophen-3-yl-1H-imidazo[4,5-f][1,10]phenanthroline);diisothiocyanate
CID 168344346
iron(2+);bis(2-thiophen-2-yl-1H-imidazo[4,5-f][1,10]phenanthroline);diisothiocyanate
CID 168344347
2-[4-[4-[3,3,4,4,5,5-hexafluoro-2-[5-[4-(1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenyl]-2-methylthiophen-3-yl]cyclopenten-1-yl]-5-methylthiophen-2-yl]phenyl]-1H-imidazo[4,5-f][1,10]phenanthroline
CID 101418488
5-(1H-imidazol-2-yl)-4-[9-[8-[8-[5-(1H-imidazol-2-yl)-1,3-thiazol-4-yl]pyrido[2,3-b]indol-9-yl]dibenzothiophen-2-yl]pyrido[2,3-b]indol-8-yl]-1,3-thiazole
CID 57958352

Frequently Asked Questions

What is the IUPAC name of N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine?
The IUPAC name of N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine (CID 164955789) is N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine.
What is the SMILES notation for N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine?
The canonical SMILES for N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine is Cc1nc2ccc(Nc3nc(-c4ccccc4)cc4ncccc34)cc2s1.Cn1cnc2ccc(Nc3nc(-c4ccccc4)cc4ncccc34)cc21.c1ccc(-c2cc3ncccc3c(Nc3ccc4cc[nH]c4c3)n2)cc1.c1ccc(-c2cc3ncccc3c(Nc3ccc4ncncc4c3)n2)cc1.c1ccc(-c2cc3ncccc3c(Nc3ccc4ncsc4c3)n2)cc1.c1ccc(-c2cc3ncccc3c(Nc3cccc4cc[nH]c34)n2)cc1.
What is the InChIKey of N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine?
The InChIKey is BDMLQDXBINGJKV-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H17N5.C22H15N5.C22H16N4S.2C22H16N4.C21H14N4S/c1-27-14-24-18-10-9-16(12-21(18)27)25-22-17-8-5-11-23-20(17)13-19(26-22)15-6-3-2-4-7-15;1-2-5-15(6-3-1)20-12-21-18(7-4-10-24-21)22(27-20)26-17-8-9-19-16(11-17)13-23-14-25-19;1-14-24-18-10-9-16(12-21(18)27-14)25-22-17-8-5-11-23-20(17)13-19(26-22)15-6-3-2-4-7-15;1-2-6-15(7-3-1)19-14-20-17(9-5-12-23-20)22(26-19)25-18-10-4-8-16-11-13-24-21(16)18;1-2-5-15(6-3-1)20-14-21-18(7-4-11-23-21)22(26-20)25-17-9-8-16-10-12-24-19(16)13-17;1-2-5-14(6-3-1)18-12-19-16(7-4-10-22-19)21(25-18)24-15-8-9-17-20(11-15)26-13-23-17/h2-14H,1H3,(H,25,26);1-14H,(H,26,27);2-13H,1H3,(H,25,26);2*1-14,24H,(H,25,26);1-13H,(H,24,25).
What are the key properties of N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine?
N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine has a molecular weight of 2096.51 g/mol, XLogP of 32.56, 18 rotatable bonds, 8 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1H-indol-6-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(1H-indol-7-yl)-7-phenyl-1,6-naphthyridin-5-amine;N-(3-methylbenzimidazol-5-yl)-7-phenyl-1,6-naphthyridin-5-amine;2-methyl-N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;N-(7-phenyl-1,6-naphthyridin-5-yl)-1,3-benzothiazol-6-amine;7-phenyl-N-quinazolin-6-yl-1,6-naphthyridin-5-amine is sourced from PubChem (CID 164955789), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).